Establishment of secondary iron overloaded mouse model: Evaluation of cardiac function and analysis according to iron concentration

Pediatric Cardiology

Volumn 32, Issue 7, 2011, Pages 947-952

  Moon, Se Na ^a,b   Han, Ji Whan ^a   Hwang, Hui Seung ^a   Kim, Mee Jeong ^a   Lee, Soon Ju ^a   Lee, Jae Young ^a   Oh, Chang Kyu ^a   Jeong, Dae Chul ^a,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Cardiac function; Pathology; Secondary iron overload

Indexed keywords

FERRIC FERROCYANIDE; IRON; IRON DEXTRAN; PHOSPHATE BUFFERED SALINE; ANTIANEMIC AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE MODEL; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART WEIGHT; HISTOPATHOLOGY; IMAGING SYSTEM; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER; LIVER LEVEL; LIVER WEIGHT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; SECONDARY IRON OVERLOAD; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HEMATINICS; IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; LIVER; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDIUM;

EID: 84859639718     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0019-4     Document Type: Article

References (32)

1. Abraham NG, Lutton JD (1994) Differential effects of iron and iron carrier on hematopoietic cells differentiation and human ADA gene transfer. Adv Exp Med Biol 356:199-210
2. Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE, Hilson AJ (1990) High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol 84:113-117
3. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:217-219
4. Bacon BR, Park CH, Brittenham GM, O'Neill R, Tavill AS (1985) Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. Hepatology 5:789-797
5. Barosi G, Arbustini E, Gavazzi A, Grasso M, Pucci A (1989) Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients. Eur J Haematol 42:382-388
6. Baumann PQ, Sobel BE, Tarikuz Zaman AK, Schneider DJ (2008) Gender-dependent differences in echocardiographic characteristics of murine hearts. Echocardiography 25:739-748
7. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91:9-18
8. Davis BA, O'Sullivan C, Jarritt PH, Porter JB (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 104:263-269
9. Delea TE, Hagiwara M, Phatak PD (2009) Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders. Curr Med Res Opin 25:139-147
10. Demant AW, Schmiedel A, Büttner R, Lewalter T, Reichel C (2007) Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy. Clin Res Cardiol 96:900-903
11. Deugnier Y, Turlin B (2007) Pathology of iron overlaod. World J Gastroenterol 13:4755-4760
12. Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loréal O, Brissot P, Halliday JW (1993) Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17:30-34
13. Freeman AP, Giles RW, Berdoukas VA, Talley PA, Murray IP (1989) Sustained normalization of cardiac function by chelation therapy in thalassaemia major. Clin Lab Haematol 11:299-307
14. Gabutti V, Borgna-Pignatti C (1994) Clinical manifestations and therapy of transfusional haemosiderosis. Baillieres Clin Haematol 7:919-940
15. Glickstein H, El RB, Shvartsman M, Cabantchik Z (2005) Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Blood 106:3242-3250
16. Henry WL, Nienhuis AW, Wiener M, Miller DR, Canale VC, Piomelli S (1978) Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med 64:547-555
17. Liu P, Olivieri N (1994) Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther 8:101-110
18. Lombardo T, Tamburino C, Bartoloni G, Morrone ML, Frontini V, Italia F, Cordaro S, Privitera A, Calvi V (1995) Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study. Ann Hematol 71:135-141
19. Maeda T, Shimada M, Harimoto N, Tsujita E, Maehara S, Rikimaru T, Tanaka S, Shirabe K, Maehara Y (2005) Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Hepatogastroenterology 52:187-190
20. Mamtani M, Kulkarni H (2008) Influence of iron chelators on myocardial iron and cardiac function in transfusion-dependent thalassaemia: a systematic review and meta-analysis. Br J Haematol 141:882-890
21. McLaren GD, Muir WA, Kellermeyer RW (1983) Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 19:205-266
22. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187-1194
23. Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH (2004) Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109:1877-1885
24. 2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med 84:349-364
25. Ozment CP, Turi JL (2009) Iron overload following red blood cell transfusion and its impact on disease severity. Biochim Biophys Acta 1790:694-701
26. Pantopoulos K (2008) Function of the hemochromatosis protein HFE: lessons from animal models. World J Gastroenterol 14:6893-6901
27. Porter JB (2001) Practical management of iron overload. Br J Haematol 115:239-252
28. Siah CW, Trinder D, Olynyk JK (2005) Iron overload. Clin Chim Acta 358:24-36
29. Taher A, El-Beshlawy A, Elalfy MS, Al Zir K, Daar S, Habr D, Kriemler-Krahn U, Hmissi A, Al Jefri A (2009) Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study. Eur J Haematol 82:458-465
30. Wood JC, Enriquez C, Ghugre N, Otto-Duessel M, Aguilar M, Nelson MD, Moats R, Coates TD (2005) Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann NY Acad Sci 1054:386-395
31. Wood JC, Otto-Duessel M, Gonzalez I, Aguilar MI, Shimada H, Nick H, Nelson M, Moats R (2006) Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Transl Res 148:272-280
32. Zhang D, Okada S, Kawabata T, Yasuda T (1995) An improved simple colorimetric method for quantitation of non-transferrin-bound iron in serum. Biochem Mol Biol Int 35:635-641